Tudor Constantin Bratiloveanu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tudor Constantin Bratiloveanu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Valeriu Surlin
Department of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania
2 shared publications - Adrian Cosmin Ilie
Department III Functional Science, Discipline of Public Health and Health Management, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication - Agnesa Preda
Department of Obstetrics and Gynaecology, Emergency County Hospital Craiova, 210218 Craiova, Romania
1 shared publication - Alina Doina Tănase
Department of Professional Legislation in Dental Medicine, Faculty of Dental Medicine, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
1 shared publication - Costin Teodor Streba
Department of Pneumology, University of Pharmacy and Medicine Craiova, 200349 Craiova, Romania
1 shared publication - Daniela Marinescu
Department of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania
1 shared publication
Latest Publications
- Open Access
- 16 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1592
Pre-Treatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers for Sentinel Lymph Node Positivity and Recurrence-Free Survival in Primary Cutaneous Melanoma: An Exploratory Single-Centre Retrospective Cohort Study
Background and Objectives: Systemic inflammation contributes to melanoma progression, yet the prognostic value of routinely available inflammatory ratios remains insufficiently characterized in real-world cohorts. We evaluated whether pre-treatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are independently associated with sentinel lymph node (SLN) positivity, histopathologic aggressiveness, and recurrence-free survival (RFS) in primary cutaneous melanoma. Methods: In this single-center, retrospective, exploratory, observational cohort, 87 adults with histologically confirmed primary cutaneous melanoma were stratified by pre-treatment NLR using a cut-off of 3.0 into low-NLR (n = 47) and high-NLR (n = 40) groups. Outcomes included Breslow thickness, ulceration, mitotic rate, AJCC stage, SLN status, and RFS over a median follow-up of 38.4 months. Discrimination was assessed by receiver operating characteristic (ROC) analysis, time-to-event endpoints by Kaplan–Meier and Cox proportional-hazards modelling, and SLN positivity by multivariable logistic regression. Results: High-NLR patients had thicker (median 2.1 vs. 0.8 mm, p < 0.001), more frequently ulcerated (42.5% vs. 12.8%, p = 0.003), and more advanced melanomas (early stage 27.5% vs. 68.1%, p < 0.001). SLN positivity among biopsied patients was 35.5% vs. 8.7% (p = 0.027). For RFS, NLR ≥ 3.0 carried a univariable hazard ratio (HR) of 4.32 (95% CI 1.60–11.67) and remained independently prognostic after multivariable adjustment (adjusted HR 2.87, 95% CI 1.04–7.92, p = 0.042). An NLR + PLR composite outperformed Breslow thickness for predicting SLN positivity (AUC 0.829 vs. 0.702, DeLong p = 0.041). Conclusions: In this exploratory, single-center retrospective cohort, pre-treatment NLR and PLR were inexpensive, widely available biomarkers that were associated with prognostically relevant melanoma features and outcomes. These hypothesis-generating findings suggest that inflammatory ratios could complement conventional histopathologic predictors, but they were derived and tested within a single small cohort without independent validation and require confirmation in larger, prospective, multi-center studies before any clinical application.
- 16 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1592
Open AccessPre-Treatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers for Sentinel Lymph Node Positivity and Recurrence-Free Survival in Primary Cutaneous Melanoma: An Exploratory Single-Centre Retrospective Cohort Study
Background and Objectives: Systemic inflammation contributes to melanoma progression, yet the prognostic value of routinely available inflammatory ratios remains insufficiently characterized in real-world cohorts. We evaluated whether pre-treatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are independently associated with sentinel lymph node (SLN) positivity, histopathologic aggressiveness, and recurrence-free survival (RFS) in primary cutaneous melanoma. Methods: In this single-center, retrospective, exploratory, observational cohort, 87 adults with histologically confirmed primary cutaneous melanoma were stratified by pre-treatment NLR using a cut-off of 3.0 into low-NLR (n = 47) and high-NLR (n = 40) groups. Outcomes included Breslow thickness, ulceration, mitotic rate, AJCC stage, SLN status, and RFS over a median follow-up of 38.4 months. Discrimination was assessed by receiver operating characteristic (ROC) analysis, time-to-event endpoints by Kaplan–Meier and Cox proportional-hazards modelling, and SLN positivity by multivariable logistic regression. Results: High-NLR patients had thicker (median 2.1 vs. 0.8 mm, p < 0.001), more frequently ulcerated (42.5% vs. 12.8%, p = 0.003), and more advanced melanomas (early stage 27.5% vs. 68.1%, p < 0.001). SLN positivity among biopsied patients was 35.5% vs. 8.7% (p = 0.027). For RFS, NLR ≥ 3.0 carried a univariable hazard ratio (HR) of 4.32 (95% CI 1.60–11.67) and remained independently prognostic after multivariable adjustment (adjusted HR 2.87, 95% CI 1.04–7.92, p = 0.042). An NLR + PLR composite outperformed Breslow thickness for predicting SLN positivity (AUC 0.829 vs. 0.702, DeLong p = 0.041). Conclusions: In this exploratory, single-center retrospective cohort, pre-treatment NLR and PLR were inexpensive, widely available biomarkers that were associated with prognostically relevant melanoma features and outcomes. These hypothesis-generating findings suggest that inflammatory ratios could complement conventional histopathologic predictors, but they were derived and tested within a single small cohort without independent validation and require confirmation in larger, prospective, multi-center studies before any clinical application.
- Open Access
- 29 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3743
Management of Littre Hernia—Case Report and Systematic Review of Case Reports
Littre hernia is a rare type of hernia in which a Meckel diverticulum is found in the hernia sac. Given the rare nature of this disease, little data on demographics and surgical management exists. In this article, we provide a case report of a strangulated inguinal Littre hernia and perform a systematic review of the literature. The PubMed database was searched on 5 March 2022, and all cases of Littre hernia in adults that had English abstracts or full-text were analyzed. Our primary objective was to evaluate the surgical management and outcomes of this particular type of hernia, and our secondary objectives were to assess demographic characteristics, presentation particularities, and recurrence rates. We identified 89 articles with 98 cases, including our own. Results show a high prevalence of complications described intraoperatively, with strangulation being present in up to 38.46% of patients. The laparoscopic approach was utilized in patients with femoral, inguinal, and umbilical hernias. The most commonly performed type of resection was MD resection, followed by bowel resection, while a minority of cases (5.48%) remained unresected. Mesh repair was more frequently performed in patients with MD resection. A mortality rate of 8.7% in patients who underwent bowel resection was found. A relatively high number of reports of ectopic tissue (21.21%), ulceration (12.12%), and tumors (9.09%) were found. The average follow-up was 19.5 ± 10.29 months, with no hernia recurrence. In conclusion, most cases are admitted in an emergency setting, and intestinal obstruction is frequently associated. A minimally invasive approach can be an option even for complicated hernias. MD resection or bowel resection is usually employed, depending on the extent of ischemic lesions. Patients undergoing bowel resection may be prone to worse outcomes.
- 29 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3743
Open AccessManagement of Littre Hernia—Case Report and Systematic Review of Case Reports
Littre hernia is a rare type of hernia in which a Meckel diverticulum is found in the hernia sac. Given the rare nature of this disease, little data on demographics and surgical management exists. In this article, we provide a case report of a strangulated inguinal Littre hernia and perform a systematic review of the literature. The PubMed database was searched on 5 March 2022, and all cases of Littre hernia in adults that had English abstracts or full-text were analyzed. Our primary objective was to evaluate the surgical management and outcomes of this particular type of hernia, and our secondary objectives were to assess demographic characteristics, presentation particularities, and recurrence rates. We identified 89 articles with 98 cases, including our own. Results show a high prevalence of complications described intraoperatively, with strangulation being present in up to 38.46% of patients. The laparoscopic approach was utilized in patients with femoral, inguinal, and umbilical hernias. The most commonly performed type of resection was MD resection, followed by bowel resection, while a minority of cases (5.48%) remained unresected. Mesh repair was more frequently performed in patients with MD resection. A mortality rate of 8.7% in patients who underwent bowel resection was found. A relatively high number of reports of ectopic tissue (21.21%), ulceration (12.12%), and tumors (9.09%) were found. The average follow-up was 19.5 ± 10.29 months, with no hernia recurrence. In conclusion, most cases are admitted in an emergency setting, and intestinal obstruction is frequently associated. A minimally invasive approach can be an option even for complicated hernias. MD resection or bowel resection is usually employed, depending on the extent of ischemic lesions. Patients undergoing bowel resection may be prone to worse outcomes.
- Open Access
- 10 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3118
Has COVID-19 Modified the Weight of Known Systemic Inflammation Indexes and the New Ones (MCVL and IIC) in the Assessment as Predictive Factors of Complications and Mortality in Acute Pancreatitis?
We aimed at evaluating the prognostic capacity of the inflammatory indices derived from routine complete blood cell counts in two groups of patients with acute pancreatitis from two different time periods, before and during the COVID-19 pandemic, when a high incidence of complications with surgical risk and mortality was found. Two new markers were introduced: the mean corpuscular volume to lymphocyte ratio (MCVL) and the cumulative inflammatory index (IIC), which were calculated at a baseline in the two groups of patients. Of the already established markers, none of them managed to effectively predict the complications with surgical risk and mortality, with a decrease of less than 50% in specificity in the peri-COVID group. The MCVL had the best prediction of complications with surgical risk in both the pre-COVID and peri-COVID groups, validated it as an independent factor by multivariate analysis. The IIC had the best prediction of mortality in both periods and was proven to be an independent factor by multivariate analysis. As the IIC predicted death best, we tested the occurrence of death and found that patients with PA who had an IIC > 12.12 presented a risk of death 4.08 times higher in the pre-COVID group and 3.33 times higher in the peri-COVID group. The new MCVL and IIC independent markers had a superior sensitivity and specificity in predicting surgical risk complications and, respectively, mortality in the group of patients with acute pancreatitis during the COVID-19 pandemic, which makes them widely applicable in populations with modified immune and inflammatory status. Conclusions: In patients with acute pancreatitis, MCVL has a significant predictive value regarding complications with surgical risk (abscess, necrosis, and pseudocyst), and the IIC has a significant predictive value for mortality.
- 10 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3118
Open AccessHas COVID-19 Modified the Weight of Known Systemic Inflammation Indexes and the New Ones (MCVL and IIC) in the Assessment as Predictive Factors of Complications and Mortality in Acute Pancreatitis?
We aimed at evaluating the prognostic capacity of the inflammatory indices derived from routine complete blood cell counts in two groups of patients with acute pancreatitis from two different time periods, before and during the COVID-19 pandemic, when a high incidence of complications with surgical risk and mortality was found. Two new markers were introduced: the mean corpuscular volume to lymphocyte ratio (MCVL) and the cumulative inflammatory index (IIC), which were calculated at a baseline in the two groups of patients. Of the already established markers, none of them managed to effectively predict the complications with surgical risk and mortality, with a decrease of less than 50% in specificity in the peri-COVID group. The MCVL had the best prediction of complications with surgical risk in both the pre-COVID and peri-COVID groups, validated it as an independent factor by multivariate analysis. The IIC had the best prediction of mortality in both periods and was proven to be an independent factor by multivariate analysis. As the IIC predicted death best, we tested the occurrence of death and found that patients with PA who had an IIC > 12.12 presented a risk of death 4.08 times higher in the pre-COVID group and 3.33 times higher in the peri-COVID group. The new MCVL and IIC independent markers had a superior sensitivity and specificity in predicting surgical risk complications and, respectively, mortality in the group of patients with acute pancreatitis during the COVID-19 pandemic, which makes them widely applicable in populations with modified immune and inflammatory status. Conclusions: In patients with acute pancreatitis, MCVL has a significant predictive value regarding complications with surgical risk (abscess, necrosis, and pseudocyst), and the IIC has a significant predictive value for mortality.